Johannes Smolander

9PUBLICATIONS
56CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunologyGenomics and transcriptomicsInnate immunityHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 14, 2026
TIM3 blockade with hypomethylating therapy restores NK-cell and cytotoxic CD4+ T-cell activity in patients with AML or MDS.

|Feb 04, 2026
Functionally Characterizing the Renal Cell Carcinoma Tumor-Immune Microenvironment via Patient-Derived Ex Vivo Models.

Neja Sirc, Johannes Smolander, Anita N Kumari

|Nov 16, 2025
Coralysis enables sensitive identification of imbalanced cell types and states in single-cell data via multi-level integration.

António G G Sousa, Johannes Smolander, Sini Junttila

|Oct 30, 2024
Ex vivo modeling of precision immuno-oncology responses in lung cancer.

Bassel Alsaed, Johannes Smolander, Hanna Laitinen

|Jun 07, 2024
Somatic mutations associate with clonal expansion of CD8+ T cells.

Sofie Lundgren, Mikko Myllymäki, Timo Järvinen

|Aug 25, 2023
Cell-connectivity-guided trajectory inference from single-cell data.

Johannes Smolander, Sini Junttila, Laura L Elo

Pageof 2

Frequent Collaborators

4 joint publications

Satu Mustjoki

3 joint publications

Sini Junttila

3 joint publications

Karita Peltonen

3 joint publications

Jay Klievink